Literature DB >> 21516303

Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.

Sarah J Nyante1, Marilie D Gammon, Jay S Kaufman, Jeannette T Bensen, Dan Yu Lin, Jill S Barnholtz-Sloan, Yijuan Hu, Qianchuan He, Jingchun Luo, Robert C Millikan.   

Abstract

Adipocytokines are produced by visceral fat, and levels may be associated with breast cancer risk. We investigated whether single nucleotide polymorphisms (SNPs) in adipocytokine genes adiponectin (ADIPOQ), leptin (LEP), and the leptin receptor (LEPR) were associated with basal-like or luminal A breast cancer subtypes. 104 candidate and tag SNPs were genotyped in 1776 of 2022 controls and 1972 (200 basal-like, 679 luminal A) of 2311 cases from the Carolina Breast Cancer Study (CBCS), a population-based case-control study of whites and African Americans. Breast cancer molecular subtypes were determined by immunohistochemistry. Genotype odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. Haplotype ORs and 95% CIs were estimated using Hapstat. Interactions with waist-hip ratio were evaluated using a multiplicative interaction term. Ancestry was estimated from 144 ancestry informative markers (AIMs), and included in models to control for population stratification. Candidate SNPs LEPR K109R (rs1137100) and LEPR Q223R (rs1137101) were positively associated with luminal A breast cancer, whereas ADIPOQ +45 T/G (rs2241766), ADIPOQ +276 G/T (rs1501299), and LEPR K656N (rs8129183) were not associated with either subtype. Few patterns were observed among tag SNPs, with the exception of 3 LEPR SNPs (rs17412175, rs9436746, and rs9436748) that were in moderate LD and inversely associated with basal-like breast cancer. However, no SNP associations were statistically significant after adjustment for multiple comparisons. Haplotypes in LEP and LEPR were associated with both basal-like and luminal A subtypes. There was no evidence of interaction with waist-hip ratio. Data suggest associations between LEPR candidate SNPs and luminal A breast cancer in the CBCS and LEPR intron 2 tag SNPs and basal-like breast cancer. Replication in additional studies where breast cancer subtypes have been defined is necessary to confirm these potential associations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516303      PMCID: PMC3355661          DOI: 10.1007/s10549-011-1517-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  65 in total

1.  Examining population stratification via individual ancestry estimates versus self-reported race.

Authors:  Jill S Barnholtz-Sloan; Ranajit Chakraborty; Thomas A Sellers; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

2.  Genetic model testing and statistical power in population-based association studies of quantitative traits.

Authors:  Guillaume Lettre; Christoph Lange; Joel N Hirschhorn
Journal:  Genet Epidemiol       Date:  2007-05       Impact factor: 2.135

3.  Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Authors:  Mi-Jung Kim; Jae Y Ro; Sei-Hyun Ahn; Hak Hee Kim; Sung-Bae Kim; Gyungyub Gong
Journal:  Hum Pathol       Date:  2006-07-18       Impact factor: 3.466

4.  Epidemiology of basal-like breast cancer.

Authors:  Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2007-06-20       Impact factor: 4.872

5.  Functional consequences of the human leptin receptor (LEPR) Q223R transversion.

Authors:  George Stratigopoulos; Charles A LeDuc; Naoki Matsuoka; Roee Gutman; Richard Rausch; Scott A Robertson; Martin G Myers; Wendy K Chung; Streamson C Chua; Rudolph L Leibel
Journal:  Obesity (Silver Spring)       Date:  2008-11-06       Impact factor: 5.002

6.  Association of serum adiponectin levels with breast cancer risk.

Authors:  Yasuo Miyoshi; Tohru Funahashi; Shinji Kihara; Tetsuya Taguchi; Yasuhiro Tamaki; Yuji Matsuzawa; Shinzaburo Noguchi
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

7.  Adiponectin and breast cancer risk.

Authors:  Christos Mantzoros; Eleni Petridou; Nick Dessypris; Charilaos Chavelas; Maria Dalamaga; Delia Marina Alexe; Yannis Papadiamantis; Christos Markopoulos; Evangelos Spanos; George Chrousos; Dimitrios Trichopoulos
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  In vitro and in vivo analysis of B-Myb in basal-like breast cancer.

Authors:  A R Thorner; K A Hoadley; J S Parker; S Winkel; R C Millikan; C M Perou
Journal:  Oncogene       Date:  2008-12-01       Impact factor: 9.867

9.  Leptin levels and leptin receptor polymorphism frequency in healthy populations.

Authors:  Camille C Ragin; Cher Dallal; Michael Okobia; Francesmary Modugno; Jiangying Chen; Seymour Garte; Emanuela Taioli
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

10.  Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea.

Authors:  Hee-Yeon Woo; Hyosoon Park; Chang-Seok Ki; Yong Lai Park; Won Gil Bae
Journal:  Cancer Lett       Date:  2005-07-11       Impact factor: 8.679

View more
  28 in total

1.  Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Lawrence S Engel; Jeannette T Bensen; Charles Poole; Amy H Herring; Robert C Millikan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-31       Impact factor: 4.254

Review 2.  Leptin and leptin receptor genes in relation to premenopausal breast cancer incidence and grade in Caucasian women.

Authors:  Fangyi Gu; Peter Kraft; Megan Rice; Karin B Michels
Journal:  Breast Cancer Res Treat       Date:  2011-09-25       Impact factor: 4.872

3.  Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study.

Authors:  Martha L Slattery; Abbie Lundgreen; Lisa Hines; Roger K Wolff; Gabriella Torres-Mejia; Kathy N Baumgartner; Esther M John
Journal:  Cancer Epidemiol       Date:  2015-09-26       Impact factor: 2.984

4.  The Relationship between Adiponectin and Breast Cancer.

Authors:  Burcu Erbay; Tonguç Utku Yılmaz; Ceyla Eraldemir; Nihal Üren; Çağrı Tiryaki; Emel Ergül; Zafer Utkan
Journal:  J Breast Health       Date:  2016-04-01

5.  Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Authors:  Sarah J Nyante; Marilie D Gammon; Jay S Kaufman; Jeannette T Bensen; Dan Yu Lin; Jill S Barnholtz-Sloan; Yijuan Hu; Qianchuan He; Jingchun Luo; Robert C Millikan
Journal:  Cancer Causes Control       Date:  2014-11-25       Impact factor: 2.506

Review 6.  Leptin and breast cancer: an overview.

Authors:  Mehmet Artac; Kadri Altundag
Journal:  Med Oncol       Date:  2011-08-30       Impact factor: 3.064

Review 7.  The role of adiponectin in cancer: a review of current evidence.

Authors:  Maria Dalamaga; Kalliope N Diakopoulos; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2012-04-30       Impact factor: 19.871

8.  Single-nucleotide polymorphisms in DNA bypass polymerase genes and association with breast cancer and breast cancer subtypes among African Americans and Whites.

Authors:  Leila Family; Jeannette T Bensen; Melissa A Troester; Michael C Wu; Carey K Anders; Andrew F Olshan
Journal:  Breast Cancer Res Treat       Date:  2014-11-23       Impact factor: 4.872

9.  Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.

Authors:  Katie M O'Brien; Stephen R Cole; Charles Poole; Jeannette T Bensen; Amy H Herring; Lawrence S Engel; Robert C Millikan
Journal:  Am J Epidemiol       Date:  2013-11-10       Impact factor: 4.897

Review 10.  Molecular pathways: adiponectin and leptin signaling in cancer.

Authors:  Michael N Vansaun
Journal:  Clin Cancer Res       Date:  2013-01-25       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.